. Author manuscript; available in PMC: 2014 Aug 1.

Published in final edited form as: J Thorac Cardiovasc Surg. 2012 Jul 28;146(2):296–301. doi: 10.1016/j.jtcvs.2012.07.020

Table 2.

Vasoactive Agents used by Phase

Time	Vasoactive Agent	Randomized to BiVP (n=24)		Randomized to NoP (n=26)
Entering Phase I (OR)	Dopamine	0	(0%)	1	(4%)
	Dobutamine	1	(4%)	2	(8%)
	Epinephrine	2	(8%)	3	(12%)
	Milrinone	14	(58%)	17	(65%)
	Norepinephrine	21	(88%)	22	(85%)
	Vasopressin	18	(75%)	21	(81%)
	Phenylephrine	2	(8%)	1	(4%)
Entering Phase II (OR)	Dopamine	0	(0%)	1	(4%)
	Dobutamine	1	(4%)	2	(8%)
	Epinephrine	2	(8%)	3	(12%)
	Milrinone	14	(58%)	17	(65%)
	Norepinephrine	21	(88%)	23	(88%)
	Vasopressin	17	(71%)	22	(85%)
	Phenylephrine	2	(8%)	1	(4%)
Before Phase III (ICU)	Dopamine	0	(0%)	2	(8%)
	Dobutamine	3	(13%)	2	(8%)
	Epinephrine	3	(13%)	5	(19%)
	Milrinone	14	(58%)	17	(65%)
	Norepinephrine	22	(92%)	22	(85%)
	Vasopressin	19	(79%)	23	(88%)
	Phenylephrine	1	(4%)	3	(12%)